The use of intranasal glucocorticosteroids in the treatment of persistent allergic rhinitis after COVID-19 infection

The use of intranasal glucocorticosteroids in the treatment of persistent allergic rhinitis after COVID-19 infection

Introduction. Modern algorithms for the diagnosis and treatment of allergic rhinitis (AR) recommend a stepwise approach for managing symptoms of the disease. A part of patients with AR have symptoms that indicate to the past COVID-19 followed by significant impairment of the olfactory function. The...

Full description

Bibliographic Details
Main Authors: T. Yu. Vladimirova, A. M. Popova, M. N. Popov
Format: Article
Language:Russian
Published: Remedium Group LLC 2022-05-01
Series:Медицинский совет
Subjects:
persistent allergic rhinitis
covid-19
sense of smell
intranasal glucocorticosteroids
mometasone furoate
Online Access:https://www.med-sovet.pro/jour/article/view/6875

Similar Items

Similar Items